What is the name of your organization?
Centre for Integrated Health Programs
What is the name of your solution?
CIHP: SAMPA monitoring App
Provide a one-line summary or tagline for your solution.
A digitalized inventory control system to improve stock management and rational dispensing of antibiotics.
In what city, town, or region is your solution team headquartered?
Abuja, Federal Capital Territory (FCT).
In what country is your solution team headquartered?
NGA
What type of organization is your solution team?
Nonprofit
Film your elevator pitch.
—
What specific problem are you solving?
Antibiotic misuse and poor stock management are major drivers of antimicrobial resistance (AMR), especially in Nigerian communities. Patent and Proprietary Medicine Vendors (PPMVs) and community pharmacies (CP) who operate Community Medicine Outlets (CMO) are a significant part of the healthcare landscape of private providers who account for over 70% of healthcare services in Nigeria Many CMO lack real-time inventory systems and proper data on medicine consumption (WHO, 2022), leading to stockouts, wastage, and uncontrolled antibiotic circulation, increasing risks of antimicrobial resistance.
Globally, AMR could cause up to 10 million deaths annually by 2050 without urgent intervention (WHO, 2021). In a Nigerian study, 67% of PPMVs reported the sale of antibiotics without prescriptions – considered irrational antibiotic use (Adamu et al, 2020).
However, most AMR interventions focus on hospitals, overlooking the community level where most antibiotic misuse occurs.
In rural Nigeria, CMO lack standardized records, digital tools, and regulatory oversight. Providers lack the training, technical capacity, and resources needed to implement robust stock control systems. The lack of a community-level, real-time surveillance system significantly hinders AMR control efforts.
Digitalization of stock monitoring and accountability across CMO is essential to prevent worsening health and economic impacts from AMR.
What is your solution?
CIHP proposes to revolutionize antibiotic consumption tracking and surveillance in Nigeria through the Smart Antibiotic Monitoring & Prediction Application (SAMPA). SAMPA is built on the proven success of Commodity Management Module (CMM), a component of the Nigeria Medical Record System (NigeriaMRS), an open-source electronic medical record system deployed across 19 states and the FCT.
CMM, being implemented across conventional health facilities/community care centers, has advanced stock control capabilities, including inventory tracking, stock balances, expiration monitoring, and standardized reporting. This system integrated with Global Health Information Exchange (HIE) standards allows seamless data mapping and third-party system integration used on desktop computers and mobile devices. Mobile version, compatible with Android, supports offline data entry, ideal for community-based services.
SAMPA builds on CMM, incorporating machine learning algorithms to analyze real-time stock data and predict future antibiotic demands. It will recommend optimized redistribution strategies to prevent shortages, overstocking, providing free digital inventory systems to the CMO, ensuring inclusivity and accountability. Its dashboard will allow stakeholders to view analytics/monitor program performance.
This innovative solution will enable data-driven antibiotic accountability, enhance commodity visibility at community levels, and improve equitable distribution. SAMPA is designed to ensure that life-saving antibiotics are always available where they are needed most.
Who does your solution serve, and in what ways will the solution impact their lives?
SAMPA is a game-changing digital solution that will transform the business practices of CMO operators and improve the quality of care given to the patients who access the CMO. Our target population includes CPs, PPMVs, and patients including those who are disproportionately affected by poor antibiotic access, substandard drugs, and irrational dispensing practices.
Currently, these vendors operate without structured inventory systems, leading to frequent stockouts, drug wastage, and limited data visibility for regulators. Patients bear the burden, facing inconsistent access to quality-assured antibiotics and rising AMR risks. CMO who are digitally excluded lack access to digital technology-based tools and insights, widening the equity gap in healthcare service delivery.
SAMPA will bridge this gap by equipping CMO with a free, mobile-optimized, offline-capable inventory management app, enabling real-time stock tracking, demand prediction, and reduced wastage. SAMPA provides a potential feed for real-time, location-specific data into national systems for regulators like National Agency for Food and Drug Administration and Control (NAFDAC) and Federal Ministry of Health and Social Welfare (FMoHSW), thereby enhancing surveillance, policymaking, and AMR containment.
By increasing access to digital health tools, SAMPA improves antibiotic availability, supports evidence-based regulation, and delivers safer, more equitable health outcomes in the fight against AMR.